Literature DB >> 23255129

Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.

Libor Macurek1, Jan Benada, Erik Müllers, Vincentius A Halim, Kateřina Krejčíková, Kamila Burdová, Sona Pecháčková, Zdeněk Hodný, Arne Lindqvist, René H Medema, Jiri Bartek.   

Abstract

Cells are constantly challenged by DNA damage and protect their genome integrity by activation of an evolutionary conserved DNA damage response pathway (DDR). A central core of DDR is composed of a spatiotemporally ordered net of post-translational modifications, among which protein phosphorylation plays a major role. Activation of checkpoint kinases ATM/ATR and Chk1/2 leads to a temporal arrest in cell cycle progression (checkpoint) and allows time for DNA repair. Following DNA repair, cells re-enter the cell cycle by checkpoint recovery. Wip1 phosphatase (also called PPM1D) dephosphorylates multiple proteins involved in DDR and is essential for timely termination of the DDR. Here we have investigated how Wip1 is regulated in the context of the cell cycle. We found that Wip1 activity is downregulated by several mechanisms during mitosis. Wip1 protein abundance increases from G(1) phase to G(2) and declines in mitosis. Decreased abundance of Wip1 during mitosis is caused by proteasomal degradation. In addition, Wip1 is phosphorylated at multiple residues during mitosis, and this leads to inhibition of its enzymatic activity. Importantly, ectopic expression of Wip1 reduced γH2AX staining in mitotic cells and decreased the number of 53BP1 nuclear bodies in G(1) cells. We propose that the combined decrease and inhibition of Wip1 in mitosis decreases the threshold necessary for DDR activation and enables cells to react adequately even to modest levels of DNA damage encountered during unperturbed mitotic progression.

Entities:  

Keywords:  DNA damage response; Wip1 phosphatase; cell cycle; mitotic progression; γH2AX

Mesh:

Substances:

Year:  2012        PMID: 23255129      PMCID: PMC3575454          DOI: 10.4161/cc.23057

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  61 in total

1.  Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.

Authors:  D M Koepp; L K Schaefer; X Ye; K Keyomarsi; C Chu; J W Harper; S J Elledge
Journal:  Science       Date:  2001-08-30       Impact factor: 47.728

2.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.

Authors:  Jing Li; Ying Yang; Yue Peng; Richard J Austin; Winfried G van Eyndhoven; Ken C Q Nguyen; Tim Gabriele; Mila E McCurrach; Jeffrey R Marks; Timothy Hoey; Scott W Lowe; Scott Powers
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

3.  Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.

Authors:  Jene Choi; Bonnie Nannenga; Oleg N Demidov; Dmitry V Bulavin; Austin Cooney; Cory Brayton; Yongxin Zhang; Innocent N Mbawuike; Allan Bradley; Ettore Appella; Lawrence A Donehower
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 4.  Playing the end game: DNA double-strand break repair pathway choice.

Authors:  J Ross Chapman; Martin R G Taylor; Simon J Boulton
Journal:  Mol Cell       Date:  2012-08-24       Impact factor: 17.970

5.  PPM1D is a potential target for 17q gain in neuroblastoma.

Authors:  Fumiko Saito-Ohara; Issei Imoto; Jun Inoue; Hajime Hosoi; Akira Nakagawara; Tohru Sugimoto; Johji Inazawa
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

6.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.

Authors:  Dmitry V Bulavin; Oleg N Demidov; Shin'ichi Saito; Paivikki Kauraniemi; Crissy Phillips; Sally A Amundson; Concetta Ambrosino; Guido Sauter; Angel R Nebreda; Carl W Anderson; Anne Kallioniemi; Albert J Fornace; Ettore Appella
Journal:  Nat Genet       Date:  2002-05-20       Impact factor: 38.330

Review 7.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

8.  Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

Authors:  Dmitry V Bulavin; Crissy Phillips; Bonnie Nannenga; Oleg Timofeev; Larry A Donehower; Carl W Anderson; Ettore Appella; Albert J Fornace
Journal:  Nat Genet       Date:  2004-02-29       Impact factor: 38.330

9.  Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint.

Authors:  S Geley; E Kramer; C Gieffers; J Gannon; J M Peters; T Hunt
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

10.  Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase.

Authors:  N den Elzen; J Pines
Journal:  J Cell Biol       Date:  2001-04-02       Impact factor: 10.539

View more
  24 in total

1.  LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro.

Authors:  J Jacob Wamsley; Natalia Issaeva; Hanbing An; Xinyuan Lu; Lawrence A Donehower; Wendell G Yarbrough
Journal:  Cell Cycle       Date:  2016-12-27       Impact factor: 4.534

2.  Wip1 controls the translocation of the chromosomal passenger complex to the central spindle for faithful mitotic exit.

Authors:  Xianghua Zhang; Ji Eun Park; Eun Ho Kim; Jihee Hong; Ki-Tae Hwang; Young A Kim; Chang-Young Jang
Journal:  Cell Mol Life Sci       Date:  2020-10-16       Impact factor: 9.261

3.  Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication.

Authors:  Hiroyasu Sakai; Hidetsugu Fujigaki; Sharlyn J Mazur; Ettore Appella
Journal:  Cell Cycle       Date:  2014-01-31       Impact factor: 4.534

4.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31

5.  Oncogenic WIP1 phosphatase attenuates the DNA damage response and sensitizes p53 mutant Jurkat cells to apoptosis.

Authors:  Mehtap Kilic Eren; Nur Betül Kartal; Hatice Pilevneli
Journal:  Oncol Lett       Date:  2021-04-19       Impact factor: 2.967

6.  CK1-mediated phosphorylation of FAM110A promotes its interaction with mitotic spindle and controls chromosomal alignment.

Authors:  Cecilia Aquino Perez; Monika Burocziova; Gabriela Jenikova; Libor Macurek
Journal:  EMBO Rep       Date:  2021-05-26       Impact factor: 9.071

7.  Replication checkpoint: tuning and coordination of replication forks in s phase.

Authors:  Nicole Hustedt; Susan M Gasser; Kenji Shimada
Journal:  Genes (Basel)       Date:  2013-08-19       Impact factor: 4.096

8.  Wip1 regulation: who controls a reset button?

Authors:  Raimundo Freire
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

9.  Wip1 downregulation conserves truncated DNA damage response (DDR) in mitosis.

Authors:  Bruno Vaz; Kristijan Ramadan
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

10.  Tousled-like kinase-dependent phosphorylation of Rad9 plays a role in cell cycle progression and G2/M checkpoint exit.

Authors:  Ryan Kelly; Scott K Davey
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.